FOLD 9.59 (+0.74%)
US03152W1099BiotechnologyBiotechnology

Amicus Therapeutics (FOLD) Financial Metrics

This table shows a selected set of financial data points of Amicus Therapeutics (FOLD). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -0.51 0 -27.63 4.19B -0.2 399.36M -76.53M -74.43M -151.58M 246.99M
2022 -0.82 0 -14.92 3.53B -0.29 329.23M -170.34M -191.88M -236.57M 148.81M
2021 -0.92 0 -12.52 3.13B -0.28 305.51M -206.38M -196.1M -250.46M 245.2M
2020 -1.07 0 -21.59 5.98B -0.32 260.89M -236.52M -232.56M -276.85M 163.24M
2019 -1.48 0 -6.57 2.34B -0.43 182.24M -270.43M -328.97M -356.39M 142.84M
2018 -1.88 0 -5.1 1.78B -0.49 91.25M -306.26M -322.47M -349M 79.75M
2017 -1.85 0 -7.77 2.21B -0.34 36.93M -220.01M -428.29M -284M 49.06M
2016 -1.49 0 -3.34 667.98M -0.21 4.96M -156.49M -195.14M -200.04M 187.03M
2015 -1.2 0 -8.07 1.07B -0.24 0 -104.96M -128.71M -132.12M 69.49M
2014 -0.93 0 -8.99 619.38M -0.41 1.22M -51.91M -67.01M -68.93M 24.07M
2013 -1.16 0 -2.02 120.52M -0.5 363K -46.49M -61.38M -59.63M 43.64M
2012 -1.07 0 -2.5 122.11M -0.54 18.41M -38.07M -50.24M -48.79M 33.97M
2011 -1.28 0 -2.68 118.92M -0.49 21.43M -50.84M -46.31M -44.41M 25.67M
2010 -1.98 0 -2.37 130.35M -0.56 922K -14.37M -53.76M -54.94M 29.57M
2009 -0.29 0 -13.68 89.82M -0.06 64.36M -45.18M -4.16M -6.57M 19.34M
2008 -1.75 0 -4.56 179.5M -0.27 14.97M -39.53M -37.86M -39.36M 28.07M
2007 -3.11 0 -3.46 142.28M -0.36 1.78M 14.52M -39.93M -41.17M 44.19M
2006 -62.97 0 0 0 -1.05 0 -35.92M -45.39M -46.34M 12.13M
2005 -48.69 0 0 0 -1.18 0 -21.16M -19.92M -19.97M 6.45M
2004 -28.64 0 0 0 -3.16 0 0 -8.81M -8.81M 257K
2003 -22.01 0 0 0 0 0 0 -6.64M -6.77M 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.